To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Vetter Expands its Capacities and Services for Prefilled Syringes
19-06-2012: Vetter prepares for a rising demand for prefilled syringesd. The company is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location. The line can handle batches of up to 1 million units per day and is particularly well suited for the aseptic filling of high-volume products, like vaccines.
“Vetter is continuously and strategically investing in its partnerships with international customers,” says Peter Soelkner, Vetter Managing Director. “In the area of prefilled syringes we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production.”
Contact / Request information
Request further information free of charge:
This is where you can add this news to your personal favourites
- 1Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 2Fighting listeria and other food-borne illnesses with nanobiotechnology
- 3Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 4Using human brain cells to make mice smarter
- 5Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 6Vivacta Initiates Development of Point of Care Test for Vitamin D
- 7A light switch inside the brain
- 8Researchers divide enzyme to conquer genetic puzzle
- 9New study confirms fungal infection of the foot is a risk factor for bacterial tissue infection of the leg
- 10Bayer’s Novel Anticoagulant Xarelto now also Approved in the EU
- Frost & Sullivan commends Merck Serono for its excellence in product differe ...
- Analytik Jena AG establishes subsidiary in Thailand
- Eurofins MWG Operon launches SmartSeq
- Bone Therapeutics Invests in Cell Therapy Manufacturing Facility
- SCHOTT strengthens its position in the Asian pharmaceutical market
- Evotec and Harvard University to collaborate on development of new class of antibacterials
- Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- Frost & Sullivan commends Merck Serono for its excellence in product differentiation
- SYGNIS reports results for the first quarter of 2013